Emerging mediators of airway smooth muscle dysfunction in asthma
- 6 July 2012
- journal article
- review article
- Published by Elsevier BV in Pulmonary Pharmacology & Therapeutics
- Vol. 26 (1), 105-111
- https://doi.org/10.1016/j.pupt.2012.06.011
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Neuroimmune semaphorin 4A downregulates the severity of allergic responseMucosal Immunology, 2012
- Role of semaphorin 7a signaling in transforming growth factor β1–induced lung fibrosis and scleroderma‐related interstitial lung diseaseArthritis & Rheumatism, 2011
- Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthmaNature Immunology, 2010
- Opening the flood-gates: how neutrophil-endothelial interactions regulate permeabilityTrends in Immunology, 2009
- Transcriptional regulation of cytokine function in airway smooth muscle cellsPulmonary Pharmacology & Therapeutics, 2009
- Th17 Immunity in Patients with Allergic AsthmaInternational Archives of Allergy and Immunology, 2009
- Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthmaThe Journal of Experimental Medicine, 2007
- Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthmaThorax, 2007
- Semaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosisThe Journal of Experimental Medicine, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006